gip glp 1 dual agonist GIPR/GLP-1R therapies for diabetes and weight loss—chemistry, physiology, and clinical applications Effects of tirzepatide, a dual

3,11,12,30 These simple administration instructions may be beneficial for patients who are nonadherent or have a high pill burden

This is something that individuals and employers may want to consider before opting to use or fund GLP-1 drugs for weight loss

As depicted in Table 4, exenatide exhibited the broadest spectrum, with a total of 8 potential signals indicating GLP-1 RA-induced AP, ranging from pancreatic abscess (ROR 4.20, 95% CI 1.0317.03) to pancreatic phlegmon (ROR 84.53, 95% CI 21.86326.90)

Talk to Your Prescriber About Alternatives Your licensed healthcare provider can help tailor therapy considering cost, clinical effectiveness and safety